This patent is a major milestone for RTI, solidifying the company's position as a leader in ultra-high-definition and cinematic NeoImaging™ technology. The low-dose X-ray imaging system being developed by RTI has the potential to revolutionize radiology, providing more accurate and detailed images, allowing real-time visualization, and significantly reducing patients' radiation exposure.
"We are thrilled to receive this patent for our low-dose X-ray imaging system," said Michael Sinsheimer, Chairman of RTI. "This technology has the potential to greatly improve the safety and effectiveness of dental and medical radiology. We believe this system has the potential to significantly revolutionize healthcare and beyond."
With this patent, RTI is poised to bring this breakthrough technology to the market and make a positive impact on the industry. The company is committed to continuing its research and development efforts to advance the capabilities of this system further and improve the overall patient experience.
For more information about Real Time Imaging Technologies, LLC and its low-dose X-ray imaging system, please visit the company's website at www.neoimagingtech.com
Daniel Uzbelger
Real Time Imaging Technologies, LLC
+1 267-979-9250
duzbelger@neoimagingtech.com
Explaining NeoImaging